JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Endovascular Coiling Versus Microsurgical Clipping for Patients With Ruptured Very Small Intracranial Aneurysms: Management Strategies and Clinical Outcomes of 162 Cases.

BACKGROUND: Treatments for intracranial aneurysms mainly include endovascular treatment and craniotomy. Most studies report on large intracranial aneurysms, yet treatments for very small intracranial aneurysms remain controversial. Our purpose was to explore management strategies for ruptured very small intracranial aneurysms.

METHODS: From January 2002 to September 2010, 162 consecutive patients with ruptured very small intracranial aneurysms (≤3 mm) were retrospectively analyzed by comparing procedural data, adverse events, additional procedures, and length of hospital stay between management strategies. Modified Rankin Scale was assessed at 2 months and at 1 year by a postal questionnaire and telephone interview.

RESULTS: Of the 85 patients in the microsurgical group, 79 underwent surgical clipping and 6 underwent wrapping; 77 patients underwent endovascular therapy (endovascular group), including coiling (65 cases), stent-assisted (13 cases) and balloon-assisted (7 cases) coiling, and stenting (2 cases). At 2 months, a good grade (modified Rankin Scale 0-2) was achieved in 74% of patients in the endovascular group and 69.4% of patients in the microsurgical group. At 1 year, a good grade was achieved by 84.9% in the endovascular group and 80% in the microsurgical group. Logistic regression results showed that whichever treatment option was chosen, Hunt-Hess grade, age, cerebral vasospasm, and complications contributed significantly to the prediction of outcome at 2 months.

CONCLUSIONS: Endovascular therapy for ruptured very small intracranial aneurysms was not inferior to surgical clipping and showed a slight trend toward better prognosis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app